Sentynl Therapeutics Advances Progeria Treatment with New Licensing Deal Sentynl Therapeutics has signed an agreement with PRG S&T to license Progerinin, a potential treatment for Hutchinson-Gilford Progeria Syndrome, enhancing its commitment to rare disease solutions.

Sentynl Therapeutics Advances Progeria Treatment with New Licensing Deal #United_States #Solana_Beach #Progeria #Sentynl #Progerinin

Sentynl Therapeutics Receives FDA Approval for Revolutionary Treatment of Menkes Disease with ZYCUBO® Sentynl Therapeutics has made headlines with the FDA's approval of ZYCUBO®, the first-ever therapy for treating Menkes disease in pediatric patients, promising hope.

Sentynl Therapeutics Receives FDA Approval for Revolutionary Treatment of Menkes Disease with ZYCUBO® #United_States #Solana_Beach #Menkes_Disease #Sentynl_Therapeutics #ZYCUBO

Colosseo Opens Its Doors: A Taste of Roman-Italian Culture in Solana Beach Colosseo restaurant, spearheaded by Chef Roberto Ciacciofera, has officially opened in Solana Beach, offering authentic Roman-Italian dining.

Colosseo Opens Its Doors: A Taste of Roman-Italian Culture in Solana Beach #USA #Solana_Beach #Colosseo_Restaurant #Chef_Ciacciofera #Roman_Cuisine

Evoke Pharma and QOL Medical Conclude Tender Offer Successfully Evoke Pharma and QOL Medical have announced the expiration of their recent tender offer, marking a significant transaction in the biopharmaceutical sector.

Evoke Pharma and QOL Medical Conclude Tender Offer Successfully #USA #Solana_Beach #QOL_Medical #Evoke_Pharma #GIMOTI

Sentynl Therapeutics Achieves FDA Acceptance for CUTX-101 Resubmission Sentynl Therapeutics celebrates FDA's acceptance of CUTX-101 NDA resubmission, marking progress for Menkes disease treatment. Approval could transform patient care.

Sentynl Therapeutics Achieves FDA Acceptance for CUTX-101 Resubmission #United_States #Solana_Beach #CUTX-101 #Menkes_Disease #Sentynl_Therapeutics

Scientist.com Ranks Among the Top 50 Healthcare Technology Companies for 2025 Scientist.com has been recognized as a top 50 healthcare technology innovator for 2025, paving the way for faster drug discovery through AI integration.

Scientist.com Ranks Among the Top 50 Healthcare Technology Companies for 2025 #USA #healthcare_technology #Solana_Beach #Drug_Discovery #Scientist.com

Sentynl Therapeutics Responds to FDA's Complete Response Letter on CUTX-101 Approval for Menkes Disease Sentynl Therapeutics has received a Complete Response Letter from the FDA regarding CUTX-101 for Menkes disease, outlining the path forward.

Sentynl Therapeutics Responds to FDA's Complete Response Letter on CUTX-101 Approval for Menkes Disease #United_States #Solana_Beach #CUTX-101 #Sentynl_Therapeutics #Zydus_Lifesciences

Madison Gallery Launches Radenko Milak's Four Seasons Interrupted This Fall Discover Radenko Milak's powerful watercolor series at Madison Gallery this fall, exploring climate change's impact on our perception of seasons.

Madison Gallery Launches Radenko Milak's Four Seasons Interrupted This Fall #United_States #Climate_Change #Solana_Beach #Madison_Gallery #Radenko_Milak

RETNA's Emotional Journey Explored in 'LOVE LETTER | CARTA DE AMOR' Exhibition this Fall Explore the emotional depths of RETNA's 'LOVE LETTER | CARTA DE AMOR' exhibition, highlighting themes of love, loss, and healing through powerful art.

RETNA's Emotional Journey Explored in 'LOVE LETTER | CARTA DE AMOR' Exhibition this Fall #USA #Solana_Beach #RETNA #Madison_Gallery #LOVE_LETTER

Major Settlement Proposed in Chegg, Inc. Securities Litigation Case Worth $55 Million A proposed settlement of $55 million has been announced in the Chegg, Inc. securities litigation case, impacting investors from 2020 to 2021.

Major Settlement Proposed in Chegg, Inc. Securities Litigation Case Worth $55 Million #United_States #Solana_Beach #securities_litigation #Inc #Settlement #Chegg

Sentynl Therapeutics Pioneers Breakthrough with CUTX-101 for Menkes Disease Treatment Sentynl Therapeutics has received FDA acceptance for CUTX-101's application, targeting Menkes disease, a rare disorder with no current FDA-approved treatments.

Sentynl Therapeutics Pioneers Breakthrough with CUTX-101 for Menkes Disease Treatment #United_States #Solana_Beach #CUTX-101 #Menkes_Disease #Sentynl_Therapeutics

An Evening of Style with Carson Kressley at Ballard Designs in Solana Beach Carson Kressley dazzles fans in Solana Beach at Ballard Designs' launch event, featuring cocktails and exciting design collaborations. Join the festivities!

An Evening of Style with Carson Kressley at Ballard Designs in Solana Beach #United_States #Ballard_Designs #Carson_Kressley #Breeders_Cup #Solana_Beach